Physician profile
Kevin J Geary
NPI 1760458517
$7,887.97
in general payments reported to CMS, 2019-2025
17 companies · $300 in 2025
The $300 reported for 2025 was less than what a typical Vascular Surgery provider received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,524 · 2020: $263 · 2021: $1,166 · 2022: $2,421 · 2023: $1,595 · 2024: $618 · 2025: $300.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,834 · Travel and Lodging: $619 · Education: $60.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,834.39 |
| Travel and Lodging | $619.38 |
| Education | $60.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $4,244.85 | 2021-2024 | Ellipsys Vascular Access System, Abre, Endurant Iis |
| Medtronic Vascular, INC. | $1,136.25 | 2019-2020 | |
| W. L. Gore & Associates, INC. | $798.63 | 2021-2025 | Gore Tag Conformable Thoracic Endoprosthesis |
| Silk Road Medical, INC. | $321.20 | 2022-2024 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter |
| Endologix LLC | $224.95 | 2019 | |
| Penumbra, INC. | $150.96 | 2019 | |
| Organogenesis INC. | $141.68 | 2019 | |
| Cvrx, INC. | $137.14 | 2023 | Barostim Neo System |
| Philips North America LLC | $120.89 | 2022 | |
| Janssen Pharmaceuticals, INC | $120.88 | 2021-2024 | Xarelto |
| Terumo Medical Corporation | $117.62 | 2021 | |
| Solventum Corporation | $112.84 | 2024-2025 | Activ.A.C. |
| Ethicon US, LLC | $102.73 | 2019 | |
| Csl Behring | $60.00 | 2024 | Kcentra |
| Smith+Nephew, INC. | $44.64 | 2020-2022 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Globus Medical, INC. | $33.00 | 2025 | Affix |
| Pfizer INC. | $19.71 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kevin Geary listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.